Stocks in Sweden finished slightly weaker on Thursday, with the OMX Stockholm 30 index closing down 0.12% in Stockholm trading. Sector weakness in Basic Materials, Industrials and Consumer Goods drove the session's losses.
Within the OMXS30, communications and banking names were among the stronger performers. Tele2 AB (ST:TEL2b) led gains on the index, rising 2.54% or 4.10 points to finish at 165.35. Telia Company AB (ST:TELIA) also advanced, adding 2.14% or 0.92 points to close at 43.98. Skandinaviska Enskilda Banken AB A (ST:SEBa) increased 1.03% or 2.30 points to end the session at 225.50.
On the downside, several industrial and healthcare stocks lost ground. Sandvik AB (ST:SAND) was the weakest name among the group cited, falling 1.82% or 6.80 points to close at 367.70. Hexagon AB ser. B (ST:HEXAb) slipped 1.57% or 1.54 points to 96.56, while AstraZeneca PLC (ST:AZN) dropped 1.49% or 23.00 points to finish at 1,522.50.
Market breadth on the Stockholm Stock Exchange showed more rising issues than decliners, with 367 stocks up, 340 down and 80 unchanged at the close.
Commodities and currency moves
Energy markets were active during the session. Crude oil for September delivery climbed 3.44% or 2.59 to $77.81 a barrel. Brent oil for October delivery rose 3.90% or 3.10, settling at $82.55 a barrel.
Precious metals were softer, with the December Gold Futures contract retreating 0.30% or 13.05 to trade at $4,292.15 a troy ounce.
On foreign exchange, EUR/SEK moved up 0.09% to 10.96, while USD/SEK increased 0.35% to 9.52. The US Dollar Index Futures gained 0.32%, trading at 99.86.
Summary of movers
- Top gainers on the OMXS30 included Tele2 AB (TEL2b), Telia Company AB (TELIA) and Skandinaviska Enskilda Banken AB A (SEBa).
- Largest declines were recorded by Sandvik AB (SAND), Hexagon AB ser. B (HEXAb) and AstraZeneca PLC (AZN).
- Energy contracts advanced notably while gold futures edged lower; the US dollar strengthened modestly.
This closing snapshot reflects trading activity and price moves reported for the session. It does not provide analysis beyond the reported price changes and counts of advancing, declining and unchanged issues.